Therefore, we believe that psoralen may attenuate NAFLD by ameliorating lipid deposition, decreasing lipid peroxidation, and promoting the expression of COX-2 and iNOS. Here, PTGS2 is linked to metabolic dysfunction-associated steatotic liver disease.